Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06820359 · ClinicalTrials.gov registry record · NA
Bowel Preparation in Minimally Invasive Gynecologic Surgery
A NA study of Gynecologic Disease, sponsored by Muhammad Aslam.
- Recruiting
- Registry status
- NA
- Development phase
- 166
- Enrollment target
- 2
- Study locations
NCT06820359: Recruiting NA study of Gynecologic Disease, sponsored by Muhammad Aslam.
NCT06820359 is a NA study of Gynecologic Disease that is actively recruiting participants, run by Muhammad Aslam. The registered enrollment target is 166 participants, above the 54-participant average among 3 other Gynecologic Disease trials with a reported enrollment target (207% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06820359, a NA study of Gynecologic Disease, is actively recruiting participants, sponsored by Muhammad Aslam.
- RECRUITING
- Registry status
- NA
- Development phase
- 166 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a prospective randomized study of patients who are scheduled to undergo minimally invasive robotic gynecologic surgery. Patients will be randomized to require either pre-surgical bowel preparation vs. no bowel preparation. The effect of bowel preparation on intraoperative visualization, bowel handling, intestinal load and ease of surgery will be assessed. Patient comfort and satisfaction will be assessed.
Conditions Studied
Interventions
- OTHER Bowel Preparation
- OTHER No bowel preparation
Study Locations (2)
Michigan
- Henry Ford St. John Hospital - Detroit
- Henry Ford Macomb-Oakland Hospital, Warren Campus - Warren
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2025-02-17 |
| Est. Completion | 2026-01-31 |
| Phase | NA |
What NCT06820359 shows while recruiting
NCT06820359 is an interventional study that assigns participants to a tested intervention. The registered 166 participants enrollment target is mid-sized for trials with a published cap, above the 54-participant average among 3 other Gynecologic Disease trials with a reported enrollment target (207% higher).
The record links to 1 condition, with Gynecologic Disease appearing as the primary indexed condition, and to 2 interventions - of which Bowel Preparation is the first listed.
NCT06820359 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT06820359 about?
NCT06820359 is a clinical study titled "Bowel Preparation in Minimally Invasive Gynecologic Surgery". This is a prospective randomized study of patients who are scheduled to undergo minimally invasive robotic gynecologic surgery. Patients will be randomized to require either pre-surgical bowel preparation vs. no bowel preparation. The effect of bowel preparation on intraoperative visualization, bowe...
What is the current status of trial NCT06820359?
This trial is currently recruiting. It is a NA study. The enrollment target is 166 participants. The study started on 2025-02-17. Estimated completion is 2026-01-31.
What conditions does trial NCT06820359 study?
This clinical trial studies the following conditions: Gynecologic Disease.
What interventions are being tested in trial NCT06820359?
The interventions under investigation include: Bowel Preparation (OTHER), No bowel preparation (OTHER).
Who is sponsoring clinical trial NCT06820359?
This trial is sponsored by Muhammad Aslam, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06820359 being conducted?
This trial has 2 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gynecologic Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747303 · 166 participants · Phase 2
Frameless Stereotactic Radiosurgery for Intact Brain Metastases
- NCT03806283 · 166 participants
Mechanisms of Pregnancy Vascular Adaptations
- NCT04040452 · 166 participants · Phase 4
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
- NCT04375813 · 166 participants · Phase 2
Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI